Global Swine Healthcare Market Insights Forecasts to 2033

• The Global Swine Healthcare Market Size was Valued at USD 2.72 Billion in 2023
• The Market Size is Growing at a CAGR of 8.16% from 2023 to 2033
• The Worldwide Swine Healthcare Market Size is Expected to Reach USD 5.96 Billion by 2033
• Europe is Expected to Grow the fastest during the forecast period.

The Global Swine Healthcare Market Size is Anticipated to Exceed USD 5.96 Billion by 2033, Growing at a CAGR of 8.16% from 2023 to 2033.

Market Overview

The development of treatments to avoid connected illnesses and disorders is linked to swine health and the diseases that are brought on by pigs. Congenital deformities and reproductive disorders are only two of the many illnesses that can result from pig breeding. To lessen the impact of swine illnesses on people, governmental organizations are initiating projects to safeguard and improve the health of pigs. Swine healthcare encompasses a wide range of products, methods of treatment, and diagnostic tools designed to reduce the suffering associated with swine illnesses. It focuses on developing therapies to prevent common pig-related problems including infertility and congenital abnormalities, as well as treatments for such conditions. Swine healthcare management includes data analysis, targeted research investments that reduce potential threats, and coordinated worldwide disease surveillance. Also, it entails preventing germs and viruses while boosting immunity against group diseases through timely immunizations and prudent antibiotic usage. The swine healthcare system not only offers health services to pigs but also works to reduce the risk of disease through the use of suitable diagnostic tests, pig mobility, vaccination schedules, herd health monitoring, and barn design.

Report Coverage

This research report categorizes the market for the global swine healthcare market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global swine healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global swine healthcare market.

Driving Factors

The worldwide swine healthcare industry is expanding due in large part to the growing demand for pork products. Numerous causes, including population growth, increased disposable incomes, urbanization, and shifting nutritional habits, particularly in developing nations, are to blame for this spike in demand. Rising buying power and a rise in the intake of animal proteins, particularly pig, are two effects of developing nations' expanding prosperity. In nations where dietary habits are changing due to increasing urbanization, where the pig is frequently regarded as a main protein source in traditional cuisines, this shift is especially noticeable. The development of the worldwide swine healthcare industry is mostly being driven by technological developments in healthcare solutions. To improve the health, productivity, and well-being of pigs, a broad range of innovations have been made in this field, such as precision farming solutions, digital health technology, treatment modalities, and diagnostic instruments. Disease diagnosis is one of the main areas of technical advancement in swine healthcare. The microorganisms causing infectious disorders in pigs might be quickly and accurately identified due to sophisticated diagnostic techniques such as next-generation sequencing (NGS) technologies, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) tests. Early illness identification minimizes the spread of infections and lowers financial losses for swine producers by enabling prompt intervention and focused treatment.

Restraining Factors

The management of illnesses associated with pigs has led to a sharp increase in the cost of diagnosis and treatment services, which is anticipated to hinder market growth. Swine dysentery, which affects pigs throughout the post-weaning and fattening stages, is one of the most serious infectious illnesses of the gastrointestinal system. Brachyspira hyodysenteriae is the bacterium that causes swine dysentery. Swine gastroenteritis has caused significant financial losses for hog producers across the world. The ability of a pig to eat and gain weight is affected, which might affect feed efficiency. Therefore, for a differential diagnosis of the disorders, serological methods such as PCR or cell cultures are needed. However, the market cannot grow due to their high cost in underdeveloped countries.

Market Segmentation

The global swine healthcare market share is classified into product and disease.

• The therapeutic segment is expected to hold the largest share of the global swine healthcare market during the forecast period.   

Based on the product, the global swine healthcare market is divided into diagnostic tests and therapeutic. Among these, the therapeutic segment is expected to hold the largest share of the global swine healthcare market during the forecast period. Vaccines, feed additives, anti-infectives, and parasiticides make up the therapeutics category. Pigs receive vaccinations, usually intraperitoneally, in an attempt to stimulate an immune response that might protect against a subsequent, inevitable infection with the organism that gave rise to the vaccine. A significant increase in government measures to support animal husbandry, which fuels the manufacturing of vaccines, and a growing demand for pork in wealthy nations. Investments made by biotechnology businesses in creating innovative formulations with state-of-the-art technologies to battle recently identified viruses and recently authorized treatments might have a favorable effect on market growth.

The respiratory diseases segment is expected to hold the largest share of the global swine healthcare market during the forecast period.   

Based on the disease, the global swine healthcare market is divided into exudative dermatitis, coccidiosis, respiratory diseases, swine dysentery, and porcine parvovirus. Among these, the respiratory diseases segment is expected to hold the largest share of the global swine healthcare market during the forecast period. Globally, pneumonia is a common respiratory illness that has a detrimental impact on morbidity and death. These diseases might affect animals that are afflicted and result in financial losses for producers. Using thermal infrared and RGB (red, green, and blue) imaging, computer vision technology can help detect Actinobacillus pleuropneumonia infection in pigs as well as changes in swine physiology early on. Furthermore, an increasing pig population worldwide suggests that pig farming is expanding in popularity and importance as an economic activity.

Regional Segment Analysis of the Global Swine Healthcare Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global swine healthcare market over the predicted timeframe.

 North America is anticipated to hold the largest share of the global swine healthcare market over the predicted timeframe. The key driver of market development has been recognized as the increasing occurrence of diverse animal illnesses. The worldwide swine healthcare industry is a result of evolving animal healthcare, a rise in government animal welfare initiatives, and an increase in the number of people who consume. Swine health and production are at risk from diseases including swine influenza, porcine reproductive and respiratory syndrome (PRRS), and other bacterial infections. As a result, there is a growing need for medications, immunizations, and diagnostic equipment. Further driving market expansion in North America are technological developments and advances in swine healthcare, such as the creation of innovative treatments, diagnostic methods, and precision medicine strategies. The swine business is placing more of a focus on preventative healthcare measures as a result of growing consumer awareness of food safety, animal welfare, and sustainable farming techniques.

Europe is expected to grow at the fastest pace in the global swine healthcare market during the forecast period. The German market has grown as a result of increased government efforts and advancements in veterinary treatment and diagnostics. The main companies in the country will collaborate more quickly to expand the regional market. Furthermore, as part of the German Antibiotic Resistances Strategy DART 2020, the German Cabinet has adopted new criteria for the use of antibiotics in cattle. The country's anti-infective industry is impacted by these rules.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global swine healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boehringer Ingelheim International GmbH
• Ceva Santé Animale
• Elanco Animal Health Incorporated
• Vetoquinol SA
• Virbac S.A.
• Zoetis Inc.
• IDEXX Laboratories, Inc
• Phibro Animal Health Corporation
• Innovative Diagnostics
• Merck KgaA
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In January 2024, S&P Global Animal Health awarded CIRCUMVENT CML the title of Best New Food Animal Product. This information was released by MSD Animal Health, a company of Merck & Co., Inc. As the first and only readily available, single-dose intramuscular injectable vaccine, CIRCUMVENT CML is a revolutionary development. It is intended to protect pigs three weeks of age or older against diseases caused by Lawsonia intracellularis, Mycoplasma hyopneumoniae, and Porcine Circovirus Types 2a and 2d.

• In June 2022, the program to tackle African swine disease was started by AVAC Vietnam Company Limited. The US Department of Agriculture's Agricultural Research Service verified its safety and effectiveness.

• In March 2022, Mohit Verma, an assistant professor at Purdue University, was awarded a USD million grant by the National Animal Health Laboratory Network and the National Animal Disease Preparedness and Response Program to conduct research and develop a quick test for African swine fever.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global swine healthcare market based on the below-mentioned segments: 

Global Swine Healthcare Market, By Product

• Diagnostic Tests
• Therapeutics

Global Swine Healthcare Market, By Disease

• Exudative Dermatitis
• Coccidiosis
• Respiratory Diseases
• Swine Dysentery
• Porcine Parvovirus

Global Swine Healthcare Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa